Journey Medical Corp
DERM· Nasdaq
Released May 14, 2025, after the close
10-Q filed May 15, 2025, 45 days after period end · 0001410578-25-001296
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Revenue | $13.14M | $13.03M | $12.17M | $20.80M |
| Net Income | -$4.07M | -$10.44M | -$10.14M | -$1.38M |
| EPS Diluted |
Journey Medical Corp · CIK 1867066 · Engraved from SEC EDGAR
| -$0.18 |
| -$0.53 |
| -$0.57 |
| -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.